← Every insider
Ian K. Walsh
Director. Files against HLIO. Everything below is filed with the SEC within two business days of the trade. Filed as Walsh Ian K..
Filed lines
3
2026-09-18 to 2026-09-25
Bought
—
open market
Sold
—
open market
Net
—
bought more
Every reported line
Purchases, sales, grants, option exercises and shares withheld for tax.
| Company | Action | Value |
|---|---|---|
| HLIOHelios Technologies Inc2026-09-25 | Grantderivative | — |
| HLIOHelios Technologies Inc2026-09-18 | Option exercise | $48.3K |
| HLIOHelios Technologies Inc2026-09-18 | Option exercisederivative | — |
Source: SEC Form 4 and Form 144 filings, via EDGAR. Form 144 carries no filer identifier, so those notices are matched to this page by name alone. Value is shares times the reported price, and is blank where the filing priced the transaction at zero — a grant costs its recipient nothing. Insiders sell for reasons that have nothing to do with the company, which is why a sale is not read as a signal on its own.
Follow Ian K. Walsh by email
Ian K. Walsh's new Form 4 trades, with the rest of the week's filings. One email a week, free.
Unsubscribe with one click from any email.